Biolog-id Announces the Opening of Its First Two Subsidiaries in Spain and Italy
Biolog-id, a developer of global solutions for the management of sensitive health products (red blood cells, plasma, platelets, chemotherapy preparations) based on RFID (Radio Frequency Identification) technology, has just opened its first two commercial subsidiaries in Spain and in Italy.
This first phase is part of Biolog-id’s strategy of international expansion, as these two countries are a significant growth driver for RFID traceability of health products.
Biolog Iberica was created in Barcelona and covers the Spanish and Portuguese markets.
The Italian subsidiary, Biolog Italia, is based in Milan. These two entities, which have been operational since September 2017, are headed by Biolog-id President Pierre Parent and report to a regional sales manager.
The objectives of these subsidiaries are to develop close relationships with hospitals and blood centres, to answer invitations to tender and to propose solutions in line with their needs.
“The relevance of our solutions is driving global demand and we are receiving a growing number of requests from our clients. These new establishments allow Biolog-id to increase the number of users of its healthcare solutions and accelerate its growth internationally, while providing direct local support to customers,” says Pierre Parent.